| SC 13G | 2017-06-07 | GILDER GAGNON HOWE & CO LLC | BioScrip, Inc. | 13,171,469 | 10.9% | EDGAR |
| SC 13D/A | 2017-03-08 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 12,335,314 | 10.2% | EDGAR |
| SC 13D/A | 2017-02-24 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 13,498,334 | 11.5% | EDGAR |
| SC 13G/A | 2017-02-14 | ARDSLEY ADVISORY PARTNERS | BioScrip, Inc. | 2,099,400 | 1.8% | EDGAR |
| SC 13G/A | 2017-02-14 | NORTH TIDE CAPITAL, LLC | BioScrip, Inc. | 6,750,000 | 5.7% | EDGAR |
| SC 13G/A | 2017-02-14 | Camber Capital Management LLC | BioScrip, Inc. | - | - | EDGAR |
| SC 13G | 2017-02-13 | Venor Capital Management LP | BioScrip, Inc. | 6,295,781 | 5.4% | EDGAR |
| SC 13G/A | 2017-02-09 | DIMENSIONAL FUND ADVISORS LP | BioScrip, Inc. | 1,602,548 | 1.4% | EDGAR |
| SC 13D/A | 2016-12-05 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 14,712,910 | 12.5% | EDGAR |
| SC 13D/A | 2016-10-17 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 13,785,843 | 11.7% | EDGAR |
| SC 13G/A | 2016-07-08 | BlackRock Inc. | BioScrip, Inc. | 3,942,437 | 3.6% | EDGAR |
| SC 13G | 2016-06-27 | NORTH TIDE CAPITAL, LLC | BioScrip, Inc. | 7,200,000 | 6.3% | EDGAR |
| SC 13D/A | 2016-06-22 | GAMCO INVESTORS, INC. ET AL | BioScrip, Inc. | 14,507,800 | 12.7% | EDGAR |
| SC 13D/A | 2016-06-22 | Coliseum Capital Management, LLC | BioScrip, Inc. | 23,182,758 | 17.6% | EDGAR |
| SC 13D/A | 2016-04-05 | Coliseum Capital Management, LLC | BioScrip, Inc. | 18,665,024 | 21.7% | EDGAR |
| SC 13G/A | 2016-02-16 | ARDSLEY ADVISORY PARTNERS | BioScrip, Inc. | 2,478,100 | 3.6% | EDGAR |
| SC 13G/A | 2016-02-12 | Camber Capital Management LLC | BioScrip, Inc. | - | - | EDGAR |
| SC 13G/A | 2016-02-10 | VANGUARD GROUP INC | BioScrip, Inc. | 2,426,388 | 3.5% | EDGAR |
| SC 13G/A | 2016-02-10 | RBC Global Asset Management (U.S.) | BioScrip, Inc. | 2,846,708 | 4.1% | EDGAR |
| SC 13G/A | 2016-02-09 | DIMENSIONAL FUND ADVISORS LP | BioScrip, Inc. | 2,284,100 | 3.3% | EDGAR |